R&D Partner Content Welcome to the 2nd Raw Materials for Cell & Gene Therapy Sum... Streamline Supply Chain Communications to Optimize Phase Appropriate QC Testing, Comparability & GMP Manufacturing of Raw Materials...
R&D Partner Content Network With EHS Professionals - EHS&S for Biopharma West Advancing Biosafety & Sustainability in R&D & Manufacturing
R&D Partner Content The World's Definitive Degrader & Proximity-Based Drugs Even... The 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities
R&D Partner Content Welcome to the 7th Exosome-Based Therapeutic Development Sum... Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
R&D Partner Content Welcome to the 10th CDD for Biologics Summit Celebrating 10 Years of Computational Drug Development for Biologics Summit
R&D Partner Content 8th Neuropsychiatric Drug Development Summit The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum, capturing advancements across discovery...
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.